Scott J. Rusco, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6360 159th St, Suites D& E, Oak Forest, IL 60452 Phone: 708-535-6204 Fax: 708-535-6431 |
Dr. Jose Mario R. Flores, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15900 S. Cicero Ave, Oak Forest, IL 60452 Phone: 708-687-7200 |
Dr. Frank A. Donatello, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6360 W. 159th Street, Suites D & E, Oak Forest, IL 60452 Phone: 708-535-6204 Fax: 708-535-6431 |
Nancy Mrozek, APN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15430 Lavergne Ave, Oak Forest, IL 60452 Phone: 708-979-4071 |
News Archive
An educational program for parents helps to reduce pressure on children to eat—which may reduce the child's risk of obesity, reports a study in the September Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.
A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.
Educating individuals about the costs of healthcare could save money and lead to a more efficient use of the healthcare system, report policy researchers at Tufts University School of Medicine and Boston University School of Public Health. The study is the first to assess the effect of knowledge and perceptions of cost-sharing levels (the percentage of cost borne by individuals out of total healthcare costs) on self-reported and actual behavior.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
› Verified 1 days ago